Literature DB >> 7565860

A novel type of X-ray-sensitive Chinese hamster cell mutant with radioresistant DNA synthesis and hampered DNA double-strand break repair.

G W Verhaegh1, W Jongmans, B Morolli, N G Jaspers, G P van der Schans, P H Lohman, M Z Zdzienicka.   

Abstract

It has been shown that the Chinese hamster cell mutant V-C8 is sensitive to different DNA damaging agents, such as mitomycin C (MMC), alkylating agents, UV light, and X-rays. We found that V-C8 is also sensitive to the following radiomimetic agents: bleomycin (approximately 2-fold, based on D10 values), H2O2 (approximately 2-fold), streptonigrin (approximately 11-fold), and etoposide (approximately 8-fold). Two independent spontaneous MMC-resistant revertants isolated from V-C8 cells show a level of cell killing by X-rays, EMS, and UV light which is similar to that of wild-type cells, suggesting that the observed pattern of cross-sensitivity of V-C8 cells to a wide spectrum of DNA damaging agents results from a single mutation. V-C8 cells also display radioresistant DNA synthesis following gamma-irradiation which, however, remained almost unchanged in the V-C8 revertants. The measurement of the level and rate of repair of DNA single- and double-strand breaks (SSBs and DSBs, respectively) by the DNA elution technique showed that the V-C8 mutant has a slower repair of DSBs induced by gamma-rays. The described unique phenotype of V-C8 cells suggested that V-C8 represents a novel type of mutant amongst X-ray-sensitive hamster cell mutants. To confirm this, complementation analysis with other X-ray-sensitive mutants was performed. V-C8 cells were fused with EM9, XR-1, xrs5, sxi-1, V-3, V-E5, irs3, and BLM2 mutant cells, representing different complementation groups. All the obtained hybrids regained X-ray resistance (or bleomycin resistance in the case of V-C8/BLM2 hybrids) similar to that of wild-type cells, indicating that V-C8 represents a new complementation group. The results presented indicate that V-C8 is defective in a gene involved in a pathway operating in the responses to different DNA damaging agents in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565860     DOI: 10.1016/0921-8777(95)00017-e

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions.

Authors:  Maria Kraakman-van der Zwet; Wilhelmina J I Overkamp; Rebecca E E van Lange; Jeroen Essers; Annemarie van Duijn-Goedhart; Ingrid Wiggers; Srividya Swaminathan; Paul P W van Buul; Abdellatif Errami; Raoul T L Tan; Nicolaas G J Jaspers; Shyam K Sharan; Roland Kanaar; Malgorzata Z Zdzienicka
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation.

Authors:  A Errami; D M He; A A Friedl; W J Overkamp; B Morolli; E A Hendrickson; F Eckardt-Schupp; M Oshimura; P H Lohman; S P Jackson; M Z Zdzienicka
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

3.  Human Rad50 is physically associated with human Mre11: identification of a conserved multiprotein complex implicated in recombinational DNA repair.

Authors:  G M Dolganov; R S Maser; A Novikov; L Tosto; S Chong; D A Bressan; J H Petrini
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.

Authors:  Shunsuke Meike; Tohru Yamamori; Hironobu Yasui; Masato Eitaki; Akira Matsuda; Masami Morimatsu; Masakazu Fukushima; Yasundo Yamasaki; Osamu Inanami
Journal:  Mol Cancer       Date:  2011-07-28       Impact factor: 27.401

5.  Natural and glucosyl flavonoids inhibit poly(ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells.

Authors:  Junko Maeda; Erica J Roybal; Colleen A Brents; Mitsuru Uesaka; Yasushi Aizawa; Takamitsu A Kato
Journal:  Oncol Rep       Date:  2013-12-05       Impact factor: 3.906

6.  PARP Inhibition by Flavonoids Induced Selective Cell Killing to BRCA2-Deficient Cells.

Authors:  Cathy Su; Alexis H Haskins; Chisato Omata; Yasushi Aizawa; Takamitsu A Kato
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-12

7.  Hypersensitivity of BRCA2 deficient cells to rosemary extract explained by weak PARP inhibitory activity.

Authors:  Cathy Su; Jeffrey P Gius; Julia Van Steenberg; Alexis H Haskins; Kazuki Heishima; Chisato Omata; Masahiro Iwayama; Mami Murakami; Takashi Mori; Kohji Maruo; Takamitsu A Kato
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

8.  Evaluating the Genotoxic and Cytotoxic Effects of Thymidine Analogs, 5-Ethynyl-2'-Deoxyuridine and 5-Bromo-2'-Deoxyurdine to Mammalian Cells.

Authors:  Jeremy S Haskins; Cathy Su; Junko Maeda; Kade D Walsh; Alexis H Haskins; Allison J Allum; Coral E Froning; Takamitsu A Kato
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.